Scientists discover 5 FDA-approved drugs are effective at stopping coronavirus spread in the body
A massive global collaboration of scientists has discovered several possible ways we could treat COVID-19.
Dozens of researchers have discovered that five existing drugs and a range of other drug compounds are effective at blocking COVID-19 from infecting human cells, they revealed in a study published Thursday in the scientific journal Nature. While the lab study doesn't take into account the drugs' effects on other parts of the body, it "could lead to a therapeutic regimen to treat COVID-19," the study says.
To study how certain drugs affect the coronavirus, the scientists first broke down what human proteins the virus manipulates. They then looked for known drugs and experimental compounds that affect those proteins, and tested 47 of them against the virus. Five existing drugs that are already FDA-approved to treat other diseases proved effective at blocking COVID-19's spread, including the much-discussed malaria drug hydroxychloroquine. Several experimental compounds, most developed as potential cancer treatments, also proved effective.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The paper was sure to note that these tests happened outside of the human body, so no one should try taking the tested drugs unless it's in a controlled study. The University of California, San Francisco led the study, but scientists from around the world made contributions. Find the whole study here and read more about it at the San Francisco Chronicle.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
Teenage girl kills 2 in Wisconsin school shooting
Speed Read 15-year-old Natalie Rupnow fatally shot a teacher and student at Abundant Life Christian School
By Peter Weber, The Week US Published
-
Penny acquitted in NYC subway choking death
Speed Read Daniel Penny was found not guilty of homicide in the 2023 choking death of Jordan Neely
By Rafi Schwartz, The Week US Published
-
Suspect in CEO shooting caught, charged with murder
Speed Read Police believe 26-year-old Luigi Mangione killed UnitedHealthcare CEO Brian Thompson
By Peter Weber, The Week US Published
-
UnitedHealthcare CEO killed in 'brazen, targeted' hit
Speed Read Police are conducting a massive search for Brian Thompson's shooter
By Rafi Schwartz, The Week US Published
-
DOJ demands changes at 'abhorrent' Atlanta jail
Speed Read Georgia's Fulton County Jail subjects inmates to 'unconstitutional' conditions, the 16-month investigation found
By Rafi Schwartz, The Week US Published
-
China tries to bury deadly car attack
Speed Read An SUV drove into a crowd of people in Zhuhai, killing and injuring dozens — but news of the attack has been censored
By Peter Weber, The Week US Published
-
Menendez brothers may go free in LA prosecutor plan
Speed Read Prosecutors are asking for the brothers to be resentenced for the 1989 murder of their parents
By Peter Weber, The Week US Published
-
Abercrombie ex-CEO charged with sex crimes
Speed Read Mike Jeffries ran the brand during its heyday from 1992 to 2014
By Rafi Schwartz, The Week US Published